BIIB vs PCYO · P/E 21, rev $9.89B vs P/E 19, rev $26.1M
Biogen Inc (BIIB) versus Pure Cycle Corporation (PCYO) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Pure Cycle Corporation (PCYO) is a utilities - regulated water company listed on NASDAQ.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported PCYO revenue for 2025-08-31 was $26.1M. Net income was $13.1M. PCYO currently screens at market cap $263.5M and trailing P/E 19.2.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. PCYO currently screens at market cap $263.5M and trailing P/E 19.2.
Not investment advice. Open the BIIB and PCYO stock pages for the full models.
Not investment advice.